Cargando…

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein

Artemisinin is an anti-malarial drug that has shown anticancer properties. Recently, ferroptosis was reported to be induced by dihydroartemisinin (DHA) and linked to iron increase. In the current study, we determined the effect of DHA in leukemic cell lines on ferroptosis induction and iron metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grignano, E., Cantero-Aguilar, L., Tuerdi, Z., Chabane, T., Vazquez, R., Johnson, N., Zerbit, J., Decroocq, J., Birsen, R., Fontenay, M., Kosmider, O., Chapuis, N., Bouscary, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020442/ https://www.ncbi.nlm.nih.gov/pubmed/36928207 http://dx.doi.org/10.1038/s41420-023-01371-8

Ejemplares similares

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
por: Birsen, Rudy, et al.
Publicado: (2021)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia
por: Meunier, Godelieve, et al.
Publicado: (2020)

Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
por: Vazquez, Romain, et al.
Publicado: (2021)

FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
por: Levavasseur, Francoise, et al.
Publicado: (2023)

Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
por: Johnson, Natacha, et al.
Publicado: (2023)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
por: Balducci, Estelle, et al.
Publicado: (2022)

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era
por: Zerbit, Jeremie, et al.
Publicado: (2022)

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)

Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
por: Shi, Hanqiang, et al.
Publicado: (2023)

RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
por: Decroocq, Justine, et al.
Publicado: (2022)

Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice
por: Fouquet, G., et al.
Publicado: (2021)

Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO
por: Su, Ying, et al.
Publicado: (2021)

Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
por: Li, Liu-Gen, et al.
Publicado: (2022)

Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity
por: Wang, Zeng, et al.
Publicado: (2012)

Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxa-mediated pathway requiring iron and endoperoxide moiety
por: Zhao, Xuan, et al.
Publicado: (2015)

TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis
por: Gong, Hailong, et al.
Publicado: (2022)

Dihydroartemisinin-regulated mRNAs and lncRNAs in chronic myeloid leukemia
por: Li, Xiang, et al.
Publicado: (2017)

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
por: Yang, Xiao-Xin, et al.
Publicado: (2022)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Iron Metabolism in Ferroptosis
por: Chen, Xin, et al.
Publicado: (2020)

Structure of mammalian metallothionein.
por: Kägi, J H, et al.
Publicado: (1984)

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
por: Detroit, Marion, et al.
Publicado: (2023)

Crystals of cadmium, zinc metallothionein.
por: Melis, K A, et al.
Publicado: (1984)

Iron Metabolism and Ferroptosis in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2020)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

The roles of metallothioneins in carcinogenesis
por: Si, Manfei, et al.
Publicado: (2018)

Metallothionein in Brain Disorders
por: Juárez-Rebollar, Daniel, et al.
Publicado: (2017)

Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response-induced upregulation of CHAC1 expression
por: Wang, Zhiwei, et al.
Publicado: (2021)

APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis
por: Raimbault, Anna, et al.
Publicado: (2016)

Physiological and chemical characterization of cyanobacterial metallothioneins.
por: Olafson, R W
Publicado: (1986)

Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease
por: Russo, A J
Publicado: (2009)

The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010)

Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers
por: Isnawati, Ani, et al.
Publicado: (2023)

Metallothionein expression in human breast cancer.
por: Goulding, H., et al.
Publicado: (1995)

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
por: Henriquez, Soledad, et al.
Publicado: (2022)

Dietary protein effects on cadmium and metallothionein accumulation in the liver and kidney of rats.
por: Revis, N W, et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_9deutg9bt5j9pttqv8u9md33tf